TruBridge Announces Fourth Quarter and Year-End 2024 Conference Call

TruBridge, Inc. (NASDAQ: TBRG), a leading healthcare solutions company, has announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, on Monday, March 10, 2025, after the market closes. The company will host a conference call at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) on the same day to discuss its financial performance and outlook.

Investors and analysts can access the earnings call by dialing (877) 407-0890 and requesting the TruBridge earnings conference connection. Additionally, a live broadcast of the conference call will be available on the company's website at . A 30-day replay of the conference call will be accessible approximately one hour after the live broadcast concludes.

TruBridge has over four decades of experience in connecting providers, patients, and communities with innovative solutions that create real value by supporting both the financial and clinical sides of healthcare delivery. The company's industry-leading HFMA Peer Reviewed® suite of revenue cycle management (RCM) offerings combines unparalleled visibility and transparency to enhance productivity and support the financial health of healthcare organizations across all care settings.

In the third quarter of 2024, TruBridge reported total bookings of $21.0 million, compared to $15.0 million in the same quarter of the previous year, representing a 40% increase. The company's Financial Health segment, which represents the previous Revenue Cycle Management (RCM) segment, saw revenue grow to $54.3 million, compared to $46.6 million in the same quarter of the previous year, representing a 16.4% increase. Adjusted EBITDA for the Financial Health segment was $13.8 million, compared to $9.7 million in the same quarter of the previous year, indicating a 42.3% increase.

For the fourth quarter of 2024, TruBridge expects to generate total revenue between $83.5 million and $85.5 million and adjusted EBITDA between $13.5 million and $14.5 million. For the full year 2024, the company expects to generate total revenue of $335 million and $337 million and adjusted EBITDA of $49 million and $50 million.



TruBridge's strong financial performance and growth prospects are driven by several key factors, including a strong pipeline of new business, successful integration of acquisitions, expanding profitability, and the launch of new offerings. The company's acquisition of Viewgol has been successfully integrated, with operations running smoothly and contributing to the company's growth strategy. TruBridge's recently launched analytics offering is starting to resonate with initial customers and has the potential to become a significant contributor to growth.

In conclusion, TruBridge's announcement of its fourth quarter and year-end 2024 conference call highlights the company's strong financial performance and growth prospects. With a solid pipeline of new business, successful integration of acquisitions, and expanding profitability, TruBridge is well-positioned to continue its growth trajectory and support the financial health of healthcare organizations across all care settings. Investors and analysts are encouraged to participate in the conference call to gain insights into the company's financial performance and outlook.